Sign Out
Gastrointestinal disorders: Nausea, vomiting, diarrhoea, epigastric discomfort.
Immune system disorders: Anaphylactic reactions, fixed drug eruption.
Skin and subcutaneous tissue disorders: Rash. Rarely, bullous dermatitis (e.g. Stevens-Johnson syndrome, erythema multiforme).
Reporting of suspected adverse reactions: Reporting suspected adverse reactions after authorization of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via HPVC at https://hpvcth.fda.moph.go.th/.
View ADR Reporting Link
Continue with Google